BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 18645041)

  • 21. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
    Trotta T; Costantini S; Colonna G
    Mol Immunol; 2009 Dec; 47(2-3):332-9. PubMed ID: 19800124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
    Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
    Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
    Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
    Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
    Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
    Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
    Wang Y; Chen R; Gan Y; Ying S
    Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and quantification of citrullinated chemokines.
    Moelants EA; Van Damme J; Proost P
    PLoS One; 2011; 6(12):e28976. PubMed ID: 22194966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Citrullination Sites in Protein Sequences Using mRMR Method and Random Forest Algorithm.
    Zhang Q; Sun X; Feng K; Wang S; Zhang YH; Wang S; Lu L; Cai YD
    Comb Chem High Throughput Screen; 2017; 20(2):164-173. PubMed ID: 28029071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes.
    Travers TS; Harlow L; Rosas IO; Gochuico BR; Mikuls TR; Bhattacharya SK; Camacho CJ; Ascherman DP
    J Immunol; 2016 Sep; 197(5):1926-36. PubMed ID: 27448590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual specificity of anti-CXCL10-CXCL9 antibodies is governed by structural mimicry.
    Fagète S; Rousseau F; Magistrelli G; Gueneau F; Ravn U; Kosco-Vilbois MH; Fischer N
    J Biol Chem; 2012 Jan; 287(2):1458-67. PubMed ID: 22041899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca²⁺.
    Tan X; Alrashdan YA; Alkhouri H; Oliver BG; Armour CL; Hughes JM
    Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L790-802. PubMed ID: 23564506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M; Carter S; Hofer MJ; Campbell IL
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.
    Wang S; Wang Y
    Biochim Biophys Acta; 2013 Oct; 1829(10):1126-35. PubMed ID: 23860259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
    Korniejewska A; McKnight AJ; Johnson Z; Watson ML; Ward SG
    Immunology; 2011 Apr; 132(4):503-15. PubMed ID: 21255008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.
    Aguilera-Durán G; Romo-Mancillas A
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32992956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases.
    Jang B; Jeon YC; Choi JK; Park M; Kim JI; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
    Biochem J; 2012 Jul; 445(2):183-92. PubMed ID: 22551201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptidylarginine deiminase enzymes and citrullinated proteins in female reproductive physiology and associated diseases†.
    Christensen AO; Li G; Young CH; Snow B; Khan SA; DeVore SB; Edwards S; Bouma GJ; Navratil AM; Cherrington BD; Rothfuss HM
    Biol Reprod; 2022 Dec; 107(6):1395-1410. PubMed ID: 36087287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2.
    Guo Q; Bedford MT; Fast W
    Mol Biosyst; 2011 Jul; 7(7):2286-95. PubMed ID: 21584310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
    Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
    J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.